Live feed17:35:05·437dINSIDERFilingvia QuantisnowChief Executive Officer Kulkarni Samarth converted options into 13,250 shares and sold $1,006,580 worth of shares (18,568 units at $54.21), decreasing direct ownership by 3% to 189,973 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CRSP· CRISPR Therapeutics AGHealth CareOriginal source